DM Stock Overview
Engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Datametrex AI Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.045 |
| 52 Week Low | CA$0.005 |
| Beta | 2.56 |
| 11 Month Change | -50.00% |
| 3 Month Change | -50.00% |
| 1 Year Change | -80.00% |
| 33 Year Change | -97.44% |
| 5 Year Change | -75.00% |
| Change since IPO | -95.83% |
Recent News & Updates
Shareholder Returns
| DM | CA IT | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | 0.2% |
| 1Y | -80.0% | 10.0% | 21.0% |
Return vs Industry: DM underperformed the Canadian IT industry which returned 8.4% over the past year.
Return vs Market: DM underperformed the Canadian Market which returned 20.2% over the past year.
Price Volatility
| DM volatility | |
|---|---|
| DM Average Weekly Movement | 73.1% |
| IT Industry Average Movement | 9.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: DM's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: DM's weekly volatility has increased from 54% to 72% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Paul Haber | www.datametrex.com |
Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.
Datametrex AI Limited Fundamentals Summary
| DM fundamental statistics | |
|---|---|
| Market cap | CA$3.02m |
| Earnings (TTM) | -CA$17.37m |
| Revenue (TTM) | CA$8.21m |
0.4x
P/S Ratio-0.2x
P/E RatioIs DM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DM income statement (TTM) | |
|---|---|
| Revenue | CA$8.21m |
| Cost of Revenue | CA$5.77m |
| Gross Profit | CA$2.44m |
| Other Expenses | CA$19.81m |
| Earnings | -CA$17.37m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.029 |
| Gross Margin | 29.73% |
| Net Profit Margin | -211.50% |
| Debt/Equity Ratio | 65.5% |
How did DM perform over the long term?
See historical performance and comparison